A profile with a relatively small number of proteins (ANGPT1, TIMP1, IP10, TGFβ1) was sufficient to correctly assign 79.7% (47/59) of the astrocytoma and 65.1% (28/43) of the control subjects. This evidence concerns the gene TIMP1 and astrocytoma (excluding glioblastoma).